CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and Southeast Asia... Show more
Coca-Cola Europacific Partners (CCEP) holds a dominant position as the world's largest independent bottler for The Coca-Cola Company, operating across 31 markets in Europe, Asia-Pacific, and beyond. With exclusive bottling agreements, CCEP benefits from powerful brands like Coca-Cola, Fanta, Sprite, and Monster, securing number-one value market share in NARTD categories in major markets such as the UK, Germany, France, Iberia, and Australia. The company's balanced footprint—spanning mature European economies and high-growth emerging markets like Indonesia and the Philippines—provides resilience and expansion opportunities.
Competitive advantages include scale in production and distribution, advanced digital transformation, and investments in sustainability, such as a 2030 carbon reduction plan aligned with business growth. Medium-term positioning emphasizes portfolio diversification into healthier, low-sugar, and premium products to counter health-conscious trends and private-label competition. While structural risks like regulatory scrutiny on packaging and ingredients persist, CCEP's innovation cycle and supply chain efficiencies support sustained market share gains.
CCEP's near-term trajectory hinges on several key events. The Q1 2026 trading update, scheduled for April 28, will offer insights into early-year performance amid varying regional demand. The Annual General Meeting on May 28 could signal updates on capital allocation, including the ongoing €1 billion share buyback program and dividend growth. Full-year 2026 earnings, expected mid-year, will be pivotal for validating the 3-4% revenue growth guidance.
Analyst sentiment remains constructive, with a Moderate Buy consensus from around 18 firms. Recent price targets cluster between $93 and $118, averaging $108, reflecting optimism on organic growth and shareholder returns. Notable revisions have trended stable to slightly upward, driven by robust FY2025 results. Strategic partnerships or product launches in ready-to-drink categories could further boost sentiment, while any shifts in consensus recommendations would amplify volatility.
The non-alcoholic beverages sector is set for steady expansion, with global market growth projected at 5-7% CAGR into the late 2020s, fueled by rising demand for functional, low-calorie, and non-alcoholic options. In Europe, the market anticipates 7.6% CAGR, while Asia-Pacific benefits from urbanization and premiumization. CCEP is well-aligned, leveraging its scale to capitalize on these tailwinds.
Macro sensitivities include moderating inflation, which enhances pricing power for consumer staples like CCEP, though persistent pressures could squeeze margins if not fully passed through. Consumer spending cycles—tied to disposable income and interest rates—directly influence out-of-home consumption volumes. Commodity costs for sugar and aluminum remain a watchpoint, as does the regulatory climate around health labeling and plastic reduction. Geopolitical stability in Europe and Asia supports supply chains, but evolving ESG (environmental, social, and governance) standards could drive investment needs.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that assists traders in identifying potential bullish, bearish, or sideways movements for stocks, ETFs, and other assets over the next week or month. By analyzing vast datasets, it spots developing trends, evaluates breakout or reversal signals, and provides predictions across thousands of tradable instruments. Features include searchable prediction categories, historical performance context, and customizable alerts to keep users ahead of momentum shifts. Explore the Trend Prediction Engine today to enhance your market analysis.
Looking to 2026 and beyond, CCEP's outlook centers on delivering 3-4% revenue growth through balanced volume/mix improvements and disciplined pricing. Consensus analyst forecasts project revenue around $9.8 trillion (adjusted for scale), underscoring confidence in execution. Market expansion in Asia-Pacific, coupled with European recovery, offers structural upside, while cost efficiencies and supply chain optimizations aim to sustain margins.
Key long-term themes include sustainability transitions, with a 2030 carbon plan integrating Capex and Opex for net-zero alignment; technology adoption like AI-driven analytics for demand forecasting; and portfolio evolution toward premium, low-sugar products amid health trends. Competitive threats from agile rivals and private labels necessitate ongoing innovation. Capital allocation priorities—share buybacks, dividends, and selective M&A (mergers and acquisitions)—will shape returns. Regulatory developments on packaging and nutrition labeling remain critical, as does resilience to macroeconomic volatility. Analyst expectations, holding a Buy tilt, will evolve with delivery on these priorities.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a bottling company with interests in marketing, production and distribution of Coca-Cola products
Industry BeveragesNonAlcoholic
A.I.dvisor indicates that over the last year, CCEP has been loosely correlated with MNST. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CCEP jumps, then MNST could also see price increases.
| Ticker / NAME | Correlation To CCEP | 1D Price Change % | ||
|---|---|---|---|---|
| CCEP | 100% | +1.69% | ||
| MNST - CCEP | 44% Loosely correlated | +0.87% | ||
| PEP - CCEP | 39% Loosely correlated | +0.38% | ||
| COKE - CCEP | 36% Loosely correlated | +0.85% | ||
| KDP - CCEP | 27% Poorly correlated | +1.54% | ||
| FIZZ - CCEP | 26% Poorly correlated | -0.05% | ||
More | ||||
The 10-day moving average for CCEP crossed bullishly above the 50-day moving average on June 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 05, 2026. You may want to consider a long position or call options on CCEP as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CCEP just turned positive on June 04, 2026. Looking at past instances where CCEP's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
CCEP moved above its 50-day moving average on June 05, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CCEP advanced for three days, in of 351 cases, the price rose further within the following month. The odds of a continued upward trend are .
CCEP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCEP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CCEP entered a downward trend on June 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.850) is normal, around the industry mean (7.916). P/E Ratio (20.146) is within average values for comparable stocks, (45.556). Projected Growth (PEG Ratio) (2.862) is also within normal values, averaging (5.180). Dividend Yield (0.024) settles around the average of (0.026) among similar stocks. P/S Ratio (1.872) is also within normal values, averaging (3.329).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CCEP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.